Neurotech International has received US Food and Drug Administration (FDA) clearance for an investigational new drug […]
Neurotech International Secures FDA Green Light to Advance NTI164 Trials in the US
The Cannabis Observer
·
FOUNDING MEMBERS
First 100 readers lock in 50% off for life
Sector coverage written for operators, not tourists. Reserve founding-member pricing before launch.
- Weekday briefings on regulation, access schemes, and the companies shaping the market
- Full archive and weekly deep-dives once premium goes live
- 50% off the launch price, locked in for as long as your subscription stays active
Join 87 readers already on the waitlist
ASD
Autism Spectrum Disorder
Beyond Harmony
clinical trial
FDA
IND
Neurotech International
NTI164
Phase III
US Food and Drug Administration
Related Articles
